Atara Biotherapeutics Inc

NASDAQ:ATRA   3:59:54 PM EDT
22.98
-0.20 (-0.86%)
Other Pre-Announcement

Atara Biotherapeutics Reports Q3 Loss Per Share $0.92

Published: 11/09/2020 21:54 GMT
Atara Biotherapeutics Inc (ATRA) - Atara Biotherapeutics Announces Third Quarter 2020 Financial Results and Operational Progress.
Q3 Loss per Share $0.92.
Q3 Earnings per Share Estimate $-1.09 -- Refinitiv Ibes Data (analyst estimates).
Atara Biotherapeutics - Believes Cash, Cash Equivalents and Short-term Investments As of Sept 30, Are Sufficient to Fund Planned Operations Into 2022.
Cash, Cash Equivalents and Short-term Investments As of September 30, 2020 Totaled $327.2 Million.
Q3 Earnings per Share View $-1.09 -- Refinitiv Ibes Data (analyst estimates).